Extracorporeal CO2 Removal Devices: Global Strategic Business Report

Quick Summary:

The Extracorporeal CO2 Removal Devices market is undeniably amongst the most vital sectors in today's healthcare landscape, projected to reach a spectacular value of $137 million by 2030. This market, which currently stands at $85.7 Million, shows immense promise underpinned by continuous advancements in medical technologies and accelerated demand in regions like the U.S and China.

Our report analyzes and provides crucial insights into the numerous factors driving this market. The U.S market, already valued at $25.4 Million, China, the second-largest economy boasting a forecast 5.5% CAGR, along with other influential markets such as Japan, Canada and Germany are meticulously examined. Structured, insightful and data-driven, this report is designed to prepare you to leverage emerging opportunities, navigate challenges and stay ahead in this dynamic market environment.

Global Extracorporeal CO2 Removal Devices Market to Reach $137 Million by 2030

The global market for Extracorporeal CO2 Removal Devices estimated at US$85.7 Million in the year 2022, is projected to reach a revised size of US$137 Million by 2030, growing at a CAGR of 6% over the analysis period 2022-2030. Extracorporeal CO2 Machines, one of the segments analyzed in the report, is projected to record 6.7% CAGR and reach US$81.5 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Disposables segment is readjusted to a revised 5.5% CAGR for the next 8-year period.

The U.S. Market is Estimated at $25.4 Million, While China is Forecast to Grow at 5.5% CAGR

The Extracorporeal CO2 Removal Devices market in the U.S. is estimated at US$25.4 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$23.6 Million by the year 2030 trailing a CAGR of 5.5% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.2% and 5% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 4.5% CAGR.

Select Competitors (Total 44 Featured) -

Aferetica Srl
Alung Technologies, Inc.
ESTOR S.P.A
Getinge AB
Medica SpA
Medtronic PLC
Xenios AG

What's New?

Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
Global competitiveness and key competitor percentage market shares
Market presence across multiple geographies - Strong/Active/Niche/Trivial
Online interactive peer-to-peer collaborative bespoke updates
Access to digital archives and the publisher's Research Platform
Complimentary updates for one year

Frequently Asked Questions about the Global Market for Extracorporeal CO2 Removal Devices

What is the estimated value of the Global Market for Extracorporeal CO2 Removal Devices?

The Global Market for Extracorporeal CO2 Removal Devices was estimated to be valued at $85.7 Million in 2022.

What is the growth rate of the Global Market for Extracorporeal CO2 Removal Devices?

The growth rate of the Global Market for Extracorporeal CO2 Removal Devices is 6.0%, with an estimated value of $137 Million by 2030.

What is the forecasted size of the Global Market for Extracorporeal CO2 Removal Devices?

The Global Market for Extracorporeal CO2 Removal Devices is estimated to be worth $137 Million by 2030.

Who are the key companies in the Global Market for Extracorporeal CO2 Removal Devices?

Key companies in the Global Market for Extracorporeal CO2 Removal Devices include Aferetica Srl, Alung Technologies, Inc., ESTOR S.P.A, Getinge AB, Medica SpA, Medtronic PLC and Xenios AG.

Report Attribute	Details
No. of Pages	193
Published	October 2023
Forecast Period	2022 - 2030
Estimated Market Value ( USD ) in 2022	$ 85.7 Million
Forecasted Market Value ( USD ) by 2030	$ 137 Million
Compound Annual Growth Rate	6.0%
Regions Covered	Global

I. METHODOLOGYII. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Influencer Market Insights
World Market Trajectories
Extracorporeal CO2 Removal Devices - Global Key Competitors Percentage Market Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

Table 1: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
Table 2: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
Table 3: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
Table 4: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
Table 5: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
Table 6: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
Table 7: World Extracorporeal CO2 Removal Devices Market Analysis of Annual Sales in US$ for Years 2014 through 2030
Table 8: World Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
Table 9: World Historic Review for Extracorporeal CO2 Removal Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
Table 10: World 16-Year Perspective for Extracorporeal CO2 Removal Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2023 & 2030
Table 11: World Recent Past, Current & Future Analysis for Extracorporeal CO2 Machines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
Table 12: World Historic Review for Extracorporeal CO2 Machines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
Table 13: World 16-Year Perspective for Extracorporeal CO2 Machines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
Table 14: World Recent Past, Current & Future Analysis for Disposables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
Table 15: World Historic Review for Disposables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
Table 16: World 16-Year Perspective for Disposables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
Table 17: World Recent Past, Current & Future Analysis for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
Table 18: World Historic Review for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
Table 19: World 16-Year Perspective for Other Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
Table 20: World Recent Past, Current & Future Analysis for Venovenous by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
Table 21: World Historic Review for Venovenous by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
Table 22: World 16-Year Perspective for Venovenous by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
Table 23: World Recent Past, Current & Future Analysis for Arteriovenous by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
Table 24: World Historic Review for Arteriovenous by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
Table 25: World 16-Year Perspective for Arteriovenous by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
Table 26: World Recent Past, Current & Future Analysis for Bridge To Lung Transplant by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
Table 27: World Historic Review for Bridge To Lung Transplant by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
Table 28: World 16-Year Perspective for Bridge To Lung Transplant by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
Table 29: World Recent Past, Current & Future Analysis for Acute Respiratory Distress Syndrome (ARDS) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
Table 30: World Historic Review for Acute Respiratory Distress Syndrome (ARDS) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
Table 31: World 16-Year Perspective for Acute Respiratory Distress Syndrome (ARDS) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
Table 32: World Recent Past, Current & Future Analysis for Chronic Obstructive Pulmonary Disease (COPD) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
Table 33: World Historic Review for Chronic Obstructive Pulmonary Disease (COPD) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
Table 34: World 16-Year Perspective for Chronic Obstructive Pulmonary Disease (COPD) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
Table 35: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
Table 36: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
Table 37: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
Table 38: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
Table 39: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
Table 40: World 16-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
Table 41: World Recent Past, Current & Future Analysis for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
Table 42: World Historic Review for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
Table 43: World 16-Year Perspective for Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030

III. MARKET ANALYSIS

UNITED STATES
Extracorporeal CO2 Removal Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
CANADA
JAPAN
Extracorporeal CO2 Removal Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
CHINA
Extracorporeal CO2 Removal Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
EUROPE
Extracorporeal CO2 Removal Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
FRANCE
Extracorporeal CO2 Removal Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
GERMANY
Extracorporeal CO2 Removal Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
ITALY
UNITED KINGDOM
Extracorporeal CO2 Removal Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
REST OF EUROPE
ASIA-PACIFIC
Extracorporeal CO2 Removal Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
REST OF WORLD

IV. COMPETITION

Companies Mentioned

A selection of companies mentioned in this report includes:

Aferetica Srl
Alung Technologies, Inc.
ESTOR S.P.A
Getinge AB
Medica SpA
Medtronic PLC
Xenios AG

Quick Summary:

Global Extracorporeal CO2 Removal Devices Market to Reach $137 Million by 2030

The U.S. Market is Estimated at $25.4 Million, While China is Forecast to Grow at 5.5% CAGR

Select Competitors (Total 44 Featured) -

What's New?

What is the estimated value of the Global Market for Extracorporeal CO2 Removal Devices?

What is the growth rate of the Global Market for Extracorporeal CO2 Removal Devices?

What is the forecasted size of the Global Market for Extracorporeal CO2 Removal Devices?

Who are the key companies in the Global Market for Extracorporeal CO2 Removal Devices?

Table of Contents

Companies Mentioned

Related Topics

Related Reports

Respiratory Devices Market, by Product Type, by End User (Hospitals, Ambulatory Surgical Centers, Clinics, and Others, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Global Extracorporeal CO2 Removal Market Size, Trends, Growth Opportunities, Market Share, Outlook by Types, Applications, Countries, and Companies to 2030

Global Extracorporeal CO2 Removal Devices Market by Product (Disposables, Extracorporeal CO2 Machines), Access (Arteriovenous, Venovenous), Application, End-use - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Forecast 2023-2030

Extracorporeal CO2 Removal Devices Market by Product, Access, Application, End Use, and by Region - Global Forecast to 2022-2033

Extracorporeal CO2 Removal Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type